Quotables
"Man will not fly for 50 years."
Wilbur Wright ; 1901
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8163778 | Pyridines as FBPase inhibitors for treatment of diabetes Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof wherein the residues have the significance given in claim 1 and which can be used in the form of pharmaceutical compositions. | 04/24/2012 |
| 8129423 | Imidazolone and imidazoloidinone derivatives as 11b-HSD1 inhibitors Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R6 have the significance given in claim 1 can be used in the form of pharmaceutical compositio... | 03/06/2012 |
| 8124636 | Imidazolidinone derivatives as 11B-HSD1 inhibitors Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein A and R1 to R4 have the significance given in claim 1 can be used in the form of pharmaceutical composition... | 02/28/2012 |
| 8093385 | Leukotriene Binhibitors Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 01/10/2012 |
| 8093253 | Leukotriene Binhibitors Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 01/10/2012 |
| 8088936 | Leukotriene B4 inhibitors Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 01/03/2012 |
| 8076334 | Prodrugs of thyroid hormone analogs Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical composition... | 12/13/2011 |
| 8039495 | Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 10/18/2011 |
| 8030308 | Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitors The invention is concerned with novel heterobicyclic derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6, V, W, X and Y are as defined in the descripti... | 10/04/2011 |
| 8026365 | 4,4-disubstituted piperidine derivatives This invention relates to 4,4-disubstituted piperidine derivatives of the formula wherein A and R1 to R5 are as defined in the specification, and pharmaceutically acceptable salts thereof. The inventio... | 09/27/2011 |
| 8026255 | Substituted piperidines as somatostatin receptor subtype 5 (SSTR5) antagonists This invention is concerned with compounds of the formula and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their prepara... | 09/27/2011 |
| 8017773 | Cyclohexyl sulfonamide derivatives The present invention relates to compounds of formula I wherein R1 to R3 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the tr... | 09/13/2011 |
| 7989454 | Leukotriene B4 inhibitors Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 08/02/2011 |
| 7973051 | Aminothiazoles as FBPase inhibitors for diabetes Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in claim 1 and which can be used in the form of pharmaceuti... | 07/05/2011 |
| 7968568 | Substituted piperidine derivatives as SST5 modulators This invention is concerned with compounds of the formula wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further re... | 06/28/2011 |
| 7964633 | Sulfonamide derivatives Compounds of formula (I) as well as pharmaceutically acceptable salts and esters thereof, wherein L, R1, R2, m and n have the meaning given in claim 1 and which can be used in the form of pharma... | 06/21/2011 |
| 7956201 | Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one The present invention relates to a process of the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one of the formula by employing a dialkylmalonate of the formula wherein R... | 06/07/2011 |
| 7947728 | Indole and indazole analogs as glycogen synthase activators Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 05/24/2011 |
| 7939661 | Pyridine, quinoline and pyrimidine derivatives This invention is concerned with compounds of the formula wherein A, R1 to R5 are as defined in the specification and G is a pyridine, quinoline or pyrimidine group as defined in the specification, and... | 05/10/2011 |
| 7939569 | Aniline analogs as glycogen synthase activators Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 05/10/2011 |
| 7935699 | Pyrazole glucokinase activators Disclosed herein are pyrazole glucokinase activators of the formula (I) useful for the treatment of metabolic diseases and disorders, preferably diabetes mellitus. ... | 05/03/2011 |
| 7906546 | Tetrahydrocarbazoles and derivatives The present invention relates to compounds of the formula (I) wherein R1, R2, R3, R4, R5, X1, X2, X3, X4, n, and k are defin... | 03/15/2011 |
| 7902248 | Oxime glucokinase activators Disclosed herein are pyrazole glucokinase activators of the formula (I): that are useful for the treatment of metabolic diseases and disorders. ... | 03/08/2011 |
| 7897815 | Hexafluoroisopropanol derivatives The invention is concerned with novel hexafluoroisopropanol derivatives of formula (I) wherein R1 to R6, m and n are as defined in the description and in the claims, as well as physiologically acceptab... | 03/01/2011 |
| 7879845 | Bicyclic sulfonamide derivatives which are L-CPT1 inhibitors The invention is concerned with novel heterobicyclic derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6, V, W, X and Y are as defined in the descripti... | 02/01/2011 |
| 7868031 | Propionamide compounds as antiinflammatory agents The present invention relates to propionamide compounds of formula I for use as antiinflammatory agents: wherein R1, R2 and R3 are as defined herein and pharmaceutically acceptable salts the... | 01/11/2011 |
| 7868030 | FBPase inhibitors for diabetes Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in the application and which can be used in the form of pharmaceutical... | 01/11/2011 |
| 7855194 | Pyrimidine, quinazoline, pteridine and triazine derivatives This invention is concerned with compounds of the formula wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further re... | 12/21/2010 |
| 7807674 | Thyroid hormone analogs Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 10/05/2010 |
| 7803819 | DPP IV inhibitors The present invention relates to compounds of formula (I) wherein R1, R2, and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for... | 09/28/2010 |
| 7803816 | MCH receptor antagonists Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 09/28/2010 |
| 7799806 | Substituted n-benzyl piperidines as somatostatin receptor modulators This invention relates to compounds of the formula wherein A, R1 to R3 are as defined in the claims and G is benzoimidazole, quinoxaline, benzotriazole, dihydro-imidazo[4,5-c]pyridinone and dihydro-iso... | 09/21/2010 |
| 7790711 | Inhibitors of 11β-Hydroxysteroid Dehydrogenase Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositi... | 09/07/2010 |
| 7786128 | Indole or benzimidazole derivatives as CBinverse agonists Provided are compounds of the formula I: and pharmaceutically acceptable salts thereof, processes for making said compounds and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising said compound... | 08/31/2010 |
| 7786109 | Tricyclic amide derivatives as modulators of H3 receptors The present invention relates to compounds of formula I wherein A, G, r and R1 to R5 are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are usefu... | 08/31/2010 |
| 7772264 | Salt and polymorphs of a DPPIV inhibitor The invention is concerned with (S)-1-{[2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile mesylate and crystalline polymorphs of this compound. This compound and its polymorphic forms exhibits superior properties compared to the previo... | 08/10/2010 |
| 7772253 | Amide derivatives as somatostatin receptor 5 antagonists This invention is concerned with compounds of the formula wherein R1 to R5, R5′ and A are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The inven... | 08/10/2010 |
| 7754744 | Substituted piperidinamines as somatostatin receptor subtype 5 (SSTR5) antagonists This invention is concerned with compounds of the formula and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their prepara... | 07/13/2010 |
| 7754736 | 5-aminoindole derivatives as H3 inverse agonists The present invention relates to compounds of formula I wherein R1, R2, R3, R4 and m are as defined in the description and claims, and pharmaceutically acceptable salts thereof as... | 07/13/2010 |
| 7745479 | 1,5-substituted indol-2-yl amide derivatives The present invention relates to compounds of formula I wherein R1 to R4 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for t... | 06/29/2010 |
